Compounders urge FDA to reject Wyeth petition

At the Total Pharmacy Solutions Summit Spring 2025, Ashley Keller, CPhT, discussed innovative ways to make pharmacy businesses thrive and, in turn, benefit patients.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.

Investigators find that the risk for new-onset diabetes is especially prominent for patients aged 20 to 29 years.

This novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.